Saiama N. Waqar
Saiama N. Waqar, MBBS, MSCI

Chair, Lung-MAP Medical Oncology, Lung-MAP Sub-Study; Associate professor of medicine, director, Hematology and Oncology Fellowship Program, Washington University School of Medicine in St. Louis

Latest Stories

FreeGuest Editorial
This is a formidable challenge. Cancer trials were, and remain, notoriously time-consuming to launch, expensive to run, and difficult to enroll patients to. A deeper understanding of cancer biology and the genomics revolution in medicine have changed how we approach clinical research.When the Lung-MAP trial was launched in June 2014, the goal was simple: Make drug development faster and more collaborative—and do it for lung cancer, the leading cause of cancer death in the United States.